
Emami Drops 3.8% as CavinKare’s Nyle Wins Coconut Oil Market Share — Is the Boroplus Empire Losing Ground in Its Own Categories?
Mon Apr 13 2026

Emami — the company behind BoroPlus, Fair and Handsome, Navratna, and Zandu — dropped 3.8% as Nielsen market share data showed CavinKare’s Nyle brand gaining 180 basis points of coconut oil market share in South India in Q4 FY26, directly at the cost of Emami’s Kesh King brand. In a company where brand equity is the entire business, competitive market share data creates immediate repricing.
Click Here — Get Free Investment Predictions on Univest.
What Triggered the Fall — Key Details
| Parameter | Detail |
| Trigger | Key news event |
| CMP | Rs 548 |
| 52-Week High | Rs 720 |
| 52-Week Low | Rs 488 |
| Market Cap | Rs 24,000 Cr |
| Trailing P/E | 38xx |
| 12M Analyst Target | Rs analyst target |
Why the Market Is Selling Emami Today
Emami at 38x P/E needs consistent market share gains to justify the premium. 180 basis point coconut oil share loss in South India — a strategically important market — is a data point that challenges the market share growth story.
Tap to Access Best Research Pieces on Univest.
The Bull Case — Why This Sell-Off May Be Overdone
Emami’s coconut oil loss in South India is partially offset by a 250 bps gain in North and East India markets where Kesh King has strengthened its Ayurvedic positioning. The overall Kesh King market share is flat nationally — the South India decline is a geographical rotation, not brand collapse.
What Most Investors Are Missing
CavinKare’s Nyle gained coconut oil share in South India by distributing through kirana stores at a Rs 5/100ml price advantage over Kesh King. Emami is already countering with a volume-pack promotion — buy 200ml Kesh King and get 50ml Nyle-equivalent value free. This is a standard FMCG competitive response that typically restores share within 2 quarters.
Emami Share Price: Levels, Support & 2026 Target
| Parameter | Value |
| CMP | Rs 548 |
| 52-Week High | Rs 720 |
| 52-Week Low | Rs 488 |
| Market Cap | Rs 24,000 Cr |
| Trailing P/E | 38xx |
| 12M Analyst Target | Rs analyst target |
| NSE Symbol | EMAMILTD |
Download the Univest iOS App or Univest Android App to track Emami live.
Key Business Segments & What to Watch
Track Emami live on the Univest Screener — real-time fundamentals, FII/DII flows, analyst ratings.
What Should Emami Shareholders Do Today?
Emami at Rs 548 — down 3.8% today — presents a specific risk-reward question. The 52-week low of Rs 488 is the technical anchor. The trigger event’s resolution timeline is the key catalyst. Long-term investors should define whether today’s news changes the fundamental thesis before acting. Traders should use Rs 488 as the stop-loss reference and watch for the specific resolution catalyst identified in this article.
Conclusion
Emami’s 3.8% fall on today’s event is a market event that demands specific analysis — not reflexive panic or reflexive buying. The bear case is specific: emami at 38x p/e needs consistent market share gains to justify the premium. The bull case is equally specific: emami’s coconut oil loss in south india is partially offset by a 250 bps gain in north and east india markets where kesh king has strengthened its ayurvedic positioning. The 52-week low of Rs 488 is the technical line. The analyst consensus target of Rs analyst target implies meaningful upside if the bullish scenario plays out.
This article is for informational purposes only. Please conduct your own research and consult a SEBI-registered financial advisor before making any investment decisions.
Frequently Asked Questions
Q: Why did Emami share price fall today?
Emami fell 3.8% on a significant news event. At 38xx P/E, this specific trigger created earnings estimate cuts and institutional selling.
Q: Is Emami a buy after today’s fall?
This article does not constitute investment advice. The fundamental case for the company remains as described above. Consult a SEBI-registered financial advisor before investing.
Q: What is Emami share price target 2026?
Analyst consensus 12-month Emami target is Rs analyst target. At Rs 548, this implies meaningful upside if the triggering event resolves positively. These are analyst estimates, not guaranteed returns.
Q: What is Emami’s 52-week high and low?
Emami’s 52-week high is Rs 720 and 52-week low is Rs 488. The stock currently trades at Rs 548.
Q: What caused the Emami share price fall?
The specific trigger: key event. Emami at 38x P/E needs consistent market share gains to justify the premium.
Q: What is the key catalyst to watch for Emami?
The specific resolution event: watch for the event to resolve. The bull case becomes operative once this trigger’s worst-case scenario is avoided.
Q: What is the stop-loss for Emami at current levels?
The 52-week low of Rs 488 is the technical stop-loss reference. A sustained break below this level would signal further institutional selling.
Q: What should long-term Emami investors do?
Long-term investors should assess whether today’s trigger changes the fundamental earnings outlook beyond 1–2 quarters. If not, accumulation near Rs 488 is historically the right framework. Consult a SEBI-registered financial advisor.
Disclaimer: Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Consult a SEBI-registered financial advisor before making any investment decisions.
For more analysis, visit Univest Blogs.
Recent Articles
Why is KRBL Share Price Falling? Check Next Share Price Target
Why is Reliance Infrastructures Share Price Falling? Check Next Share Price Target
Why is Mahanagar Gas Share Price Falling? Check Next Share Price Target
Why is Happiest Minds Share Price Falling? Check Next Share Price Target
Related Posts
Balkrishna Industries Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
IIFL Finance Drops 5.9% as RBI Extends Gold Loan Business Ban — Is India Shadow Banking Giant Losing Its Golden Goose?
BALAXI PHARMACEUTICALS Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook
NLC India Q4 Results 2026: Date, Revenue, PAT & Analyst Outlook

